95 results

Access Cancer

Posted on 18.10.2023

Increasing Education of Breast Reconstruction for Breast Cancer Survivors

Every year during Breast Cancer Awareness Month, Breast Reconstruction Awareness Day aims to educate, engage, and empower women who have been diagnosed with breast cancer to know their breast reconstruction options, and to be confident in having an informed discussion with their care team about what’s best for them. While breast reconstruction may not be […]

By Alex Holmes Mentor EMEA Lead, J&J MedTech

Business

Posted on 22.03.2023

Can IVD market sustain stellar growth?

Europe’s in vitro diagnostics (IVD) market has expanded sharply since 2020, with demand for SARS-CoV-2 tests driving double-digit growth for the past two years. In 2020, total revenues for the IVD sector rose by 29.1%That striking growth rate was eclipsed by 2021’s unprecedented growth of 43.7%.

By Teodora Angelova Senior Manager Market Data

Business

Posted on 05.10.2022

Thinking of joining an EU project? Read our top tips

The new Innovative Health Initiative (IHI) has prompted companies in the medical technology industry to think about taking part in more EU projects. For some, this is a new opportunity to build on existing experience. For others, it’s a new venture. With the right preparation, there are real benefits on offer thanks to this exciting […]

By Patrick Boisseau Director Research and Innovation, MedTech Europe

Cardio

Posted on 29.09.2022

Early diagnosis can make all the difference to the lives of people with heart failure and other forms of cardiovascular disease

Many public health campaigns focus on the importance of identifying and acting on the symptoms of major cardiovascular disease (CVD) events, such as heart attacks and strokes, as quickly as possible. Medicine has developed so much in recent decades that these events, which were once a death sentence for the majority, are now often survivable […]

By Catherine Hodge Researcher

Digital Regulation

Posted on 15.09.2022

Should the EU rewrite the rulebook on liability in response to advances in artificial intelligence?

As lawyers we tend to use academic journals to tease out complex legal questions. (See our latest contribution to the literature here). However, today we’re taking the opportunity to discuss a hot topic with a broader audience, as we feel it will have a profound impact on the public, patients and health systems. That topic […]

By Ulrich Juknat Legal Director Regulatory Law

Getting checked

Posted on 02.05.2022

Predictive genomics: how Europe can tackle the barriers to better prevention

We need to start a conversation now about how to prepare our systems and societies for the changes on the horizon. In the second of a two-part mini-series on predictive genomics, Francesco Floridini examines how Europe can accelerate the transition. I believe technology is no longer the key barrier to unlocking the potential of predictive […]

By Francesco Florindi Strategic Partnerships Manager – Predictive Genomics, Thermo Fisher Scientific

Getting checked

Posted on 28.04.2022

Time to prepare for the revolution in predictive genomics

Predictive genomics can transform healthcare, shifting the focus towards prevention and getting better value for the money we spend. In the first of a two-part mini-series, Francesco Floridini explores this new paradigm in healthcare. Healthcare today is all about treating people who are ill. They experience symptoms, engage with the health system, and receive an […]

By Francesco Florindi Strategic Partnerships Manager – Predictive Genomics, Thermo Fisher Scientific

shutterstock_452431111
Cardio

Posted on 13.10.2021

How innovation is transforming stroke care?

Many of us know someone affected by stroke. It is the second leading cause of death globally and results in 50% of survivors being chronically disabled.[1] In Europe, the incident of stroke will have increased by 34% by the middle of the next decade. [2] The impact of stroke The impact on individuals and families […]

By Alenka Brzulja Vice President of Cardiovascular & Specialty Solutions EMEA, Johnson & Johnson Medical Devices Companies

shutterstock_1220489041 (1)
COVID-19

Posted on 12.10.2021

How can orthopaedic waiting lists be tackled?

Over the last 18 months, many hospitals were forced to postpone elective surgeries to make room for COVID-19 critical care. In the UK alone, 100,000 people had their joint replacement procedures cancelled during first wave, leaving them with untreated pain and mobility challenges. More than one-third of those waiting for a total knee or hip […]

By Torbjorn Skold Vice President EMEA DePuy Synthes Joint Reconstruction